Position in OABI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$367,752
+$176,753 QoQ
Shares Held
149,493
+22.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 143 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OABI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. OABI ranks #259 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in OABI
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $367,752 | 149,493 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $190,999 | 121,656 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $153,711 | 83,088 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $76,846 | 48,030 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $123,593 | 71,031 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,303,055 | 542,940 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,181,909 | 616,359 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,056,875 | 722,666 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,706,513 | 455,071 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,030,199 | 374,576 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,622,822 | 425,093 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,220,252 | 427,795 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,954,181 | 388,506 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,356,404 | 368,589 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,181,270 | 328,131 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||